| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |